Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biol Macromol ; 111: 514-525, 2018 May.
Article in English | MEDLINE | ID: mdl-29337101

ABSTRACT

The production, optimization, and characterization of exopolysaccharide (EPS) from Weissella confusa OF126 and the in-vitro probiotic potentials of this strain was investigated. The EPS produced on sucrose modified-MRS broth was characterized. The purified EPS had an average molecular weight of 1.1 × 106 Da. HPLC analysis revealed the presence of glucose monomers, indicating its homopolysaccharide nature. The structural characteristics of the EPS were investigated by FTIR, and NMR spectroscopy. FTIR spectroscopy revealed the presence of hydroxyl, carboxyl, N-acetyl and amine groups. NMR analysis confirmed that the EPS contained α-(1 → 6) linkage and α-(1 → 3) branched linkage. The EPS showed strong in-vitro antioxidant activity. Four significant factors were optimized using Central Composite Design (CCD) and Response Surface Methodology (RSM). The predicted optimum conditions for EPS production were cultivation time (48.50 h), sucrose concentration (24.00 g/L), pH (7.00) and yeast extract (2.50%).The EPS produced was predicted to be 3.10 g/L, while the experimental yield was 3.00 g/L. This strain was found to possess desirable probiotic attributes by its ability to survive at pH 2.0 and in the presence of bile salts (0.50% (w/v)) for 4 h. The results obtained from this study demonstrate W. confusa OF126 as a promising probiotic and the EPS produced can find useful applications in industries.


Subject(s)
Antioxidants/chemistry , Polysaccharides/chemistry , Probiotics/chemistry , Weissella/chemistry , Antioxidants/isolation & purification , Bile Acids and Salts/chemistry , Glucose/chemistry , Humans , Polysaccharides/isolation & purification , Probiotics/isolation & purification
2.
Lett Appl Microbiol ; 64(5): 379-385, 2017 May.
Article in English | MEDLINE | ID: mdl-28276067

ABSTRACT

Thirty-two lactic acid bacteria (LAB) isolates were obtained from fermenting cassava mash and wara (African soft cheese) and screened for their resistance to cadmium and lead toxicities at 550-1050 mg l-1 and probiotic potentials. Four LAB strains that tolerated the heavy metals at 1050 mg l-1 were selected for antioxidative capacities, tolerance to acid, bile salts and simulated gastric and intestinal tract and safety status. The results revealed that Weissella cibaria WD2 and Lactobacillus plantarum CaD1 exhibited comparatively higher antioxidative capacities, survived in simulated gastric and intestinal transit, tolerated acid and bile salt and possessed safety status. The two strains were employed for the in vivo studies, which was monitored in male albino Wistar rats using skim milk as a carrier for the cultures over a period of 28 days. The rats given the cultures of W. cibaria WD2 and L. plantarum CaD1 in addition with the administration of heavy metals had improved renal and hepatic impairment, while damage was observed in rats fed with cadmium and lead only. Weissella cibaria WD2 and L. plantarum CaD1 demonstrated probiotic potentials and safety status. These strains can be used to effectively amend hepatic and renal histopathological alterations in rats caused by ingestion of cadmium and lead. SIGNIFICANCE AND IMPACT OF THE STUDY: This present study highlights the presence of lactic acid bacteria (LAB) from traditional fermented foods that were cadmium and lead resistant and possessed probiotic potentials. Weissella cibaria WD2 and Lactobacillus plantarum CaD1 selected for the in vivo studies ameliorated the build-up of cadmium and lead in the organs of the animals. This indicated that good cadmium and lead binding and probiotic lactic acid bacteria can be used to prevent exposure to these heavy metals.


Subject(s)
Biodegradation, Environmental , Cadmium/metabolism , Lactobacillus plantarum/metabolism , Lead Poisoning/prevention & control , Lead/metabolism , Probiotics/pharmacology , Weissella/metabolism , Animals , Bile Acids and Salts/metabolism , Cadmium/toxicity , Fermentation , Kidney/drug effects , Kidney/microbiology , Lactobacillus plantarum/drug effects , Lactobacillus plantarum/isolation & purification , Lead/toxicity , Liver/drug effects , Liver/microbiology , Manihot/microbiology , Rats , Rats, Wistar , Weissella/drug effects , Weissella/isolation & purification
3.
J Appl Microbiol ; 114(1): 229-41, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23035976

ABSTRACT

AIM: To identify enterococci from the fermentation of milk for the production of nono, an African fermented dairy product, to determine the technological properties for suitability as starter cultures and safety as probiotics. METHODS AND RESULTS: Enterococcus faecium CM4 and Enterococcus faecium 2CM1 were isolated from raw cow's milk. The strains were phenotypically and genotypically identified. Technological properties, safety investigations, in vitro adherence properties and antimicrobial characteristics were carried out. Strong acidification and tolerance to bile salts were recorded. The strains were bile salts hydrolytic positive and no haemolysis. There was no resistance to clinically relevant antibiotics. The strains exhibited adherence to human collagen type IV, human fibrinogen and fibronectin. The bacteriocins were active against Bacillus cereus DSM 2301, Bacillus subtilis ATCC 6633, Micrococcus luteus and Listeria monocytogenes. Bacteriocins were stable at pH 4-9 and on treatment with lipase, catalase, α-amylase and pepsin, while their activity was lost on treatment with other proteases. The bacteriocins produced were heat stable at 100°C for 10 min. The bacteriocin produced by the strains was identified as enterocin A. CONCLUSIONS: The E. faecium strains in this study exhibited probiotic activity, and the safety investigations indicate their suitability as good candidates for a starter culture fermentation process. SIGNIFICANCE AND IMPACT OF THE STUDY: The use of bacteriocin-producing E. faecium strains as starter cultures in fermented foods is beneficial but, however, their safety investigations as probiotics must be greatly emphasized.


Subject(s)
Bacteriocins/isolation & purification , Enterococcus faecium/isolation & purification , Milk/microbiology , Probiotics , Animals , Bacterial Adhesion , Bacteriocins/analysis , Bile Acids and Salts/pharmacology , Dairy Products/microbiology , Enterococcus faecium/classification , Enterococcus faecium/drug effects , Fermentation , Genes, Bacterial , Microbial Sensitivity Tests , Nigeria , Protein Stability
SELECTION OF CITATIONS
SEARCH DETAIL
...